Headaches are a common symptom of a stressful lifestyle, your body not feeling well and other issues. While headaches can be dealt with easily, migraines are not so easy to handle. Migraines are a type of headache that feels like severe throbbing and pulsing sensation, almost like you are hearing your own heartbeat in your brain, usually on one side of the brain. Many people believe that migraines are not that big of a deal because you just have to deal with the pain, but that is not all migraine is, some people find it very difficult to do their daily tasks as they experience dizzying spells, nausea and extreme sensitivity to light and sound! These attacks can last hours and make it difficult for people to go about their daily lives as well. While there are medications available for migraine patients, these medications need time to take effect, so you may be in a lot of pain, but there are not many quick reliefs you can have in place other than learning the symptoms of a migraine attack and taking medication before it happens. But a new approval by the FDA may change this!

The U.S. Food and Drug Administration (FDA) has approved Symbravo, a new medicine to treat acute migraine attacks in adults. This means adults can now use Symbravo to get relief from their migraine symptoms. The FDA's decision was based on the results of three big studies, called Phase 3 trials. These trials involved over 21,000 migraine attacks, so the FDA has a lot of information about how well Symbravo works and how safe it is. The FDA only approves medicines that have been shown to be both safe and effective through a thorough testing process.

Importance of New Treatment Option

"Migraine attacks can happen suddenly and really mess up people's lives. It's estimated that over 39 million people in the U.S. alone get migraines," said Herriot Tabuteau, M.D., CEO of Axsome Therapeutics told US News. This shows how common migraines are and how important it is to have good treatments. "Symbravo gives patients and doctors a new option that can quickly stop a migraine attack, keep it away, and let people get back to their normal activities, all with just one dose." Having a medicine that can give fast and long-lasting relief from migraine pain is a big deal for millions of people. This new treatment is a real step forward in how we treat migraines.

Symbravo Trial Results, How Was It Approved

The trials took place in 3 steps, the Momentum trial study focused on people whose migraines had moderate to severe pain. The results showed that a lot more people taking Symbravo felt pain-free two hours after taking the medicine compared to those who took a placebo which is a dummy pill. Even better, many people felt relief for up to 24 and even 48 hours after just one dose. This long-lasting relief is really important for people with migraines because it means they can get back to their normal lives without worrying about the pain coming back. The study also looked at how many people were free from their worst symptom, like sensitivity to light or sound, or nausea. Symbravo worked better than the placebo in this area too.

While the intercept trial looked at people who took Symbravo when their migraine pain was still mild. Even when the pain was just starting, Symbravo was effective. The results were similar to the MOMENTUM trial, with many people getting pain relief and relief from their worst symptoms. Treating migraines early is often better because it can stop the pain from getting really bad.

And lastly the Movement trial which was to see how safe the medication is when people take it regularly. This study followed 706 people who had at least two migraines a month. The most common side effects people experienced were sleepiness and dizziness. While these side effects are important to know about, the study showed that Symbravo is generally safe for people to use on a regular basis.

India must move beyond treating hemophilia—a genetic bleeding disorder—only after bleeding episodes and focus on preventing bleeding and its complications, health experts said at the UP-Hemophilia Conclave 2026.

Hemophilia is a rare bleeding disorder where blood does not clot properly, even for minor injuries. It is caused by an error in a specific gene on the X chromosome, leading to a deficiency or absence of clotting factors.

The country has the world's second-largest population of people with hemophilia, who experience spontaneous and traumatic bleeding due to low or very low levels of clotting factors.

The World Federation of Hemophilia (WFH) reported nearly 28,000 diagnosed and registered Persons with Hemophilia (PwH) in India as of 2026, including more than 24,000 with Hemophilia A. However, the estimated prevalence could be as high as 1,36,000, suggesting many cases may remain undiagnosed or misdiagnosed. In Uttar Pradesh, around 7,700 PwH are diagnosed, including approximately 5,500 with Hemophilia A.

Although India has expanded access to modern diagnosis and treatment, including gene therapy trials and non-factor therapies (NFTs) such as emicizumab, experts said preventive care needs to be strengthened.

Experts Call For Shift To Preventive Care

Also read: Why India Must Shift Towards Prophylaxis Care For Hemophilia

Hemophilia patients should be able to lead normal lives and be managed like people with chronic conditions such as diabetes and hypertension, with regular replacement treatment to prevent complications, said Prof A. K. Tripathi, Clinical Hematologist and former Director, RMLIMS, Lucknow.

“At present, patients largely rely on reactive treatment, where therapy is given only after a bleeding episode. This approach is neither appropriate nor effective. They do not just need treatment when they bleed; they need treatment that prevents bleeding in the first place. The only way forward is to start prophylaxis,” he said.

Why Is Prophylaxis Important?

Repeated joint bleeding can cause lasting damage, making it difficult to walk and, in severe cases, leaving patients chair-bound or bed-bound.

Regular replacement treatment, or prophylaxis, can protect joints and muscles and improve quality of life, said Dr S. P. Verma, Professor and Head, Department of Clinical Hematology, King George's Medical University (KGMU), Lucknow.

“Preventive treatment through regular replacement therapy (prophylaxis) has emerged as the global standard of care. This changing treatment landscape presents an opportunity to strengthen preventive care and improve long-term outcomes for patients,” said Dr Nita Radhakrishnan, Professor and HOD, Pediatric Hematology and Oncology, Post Graduate Institute of Child Health (PGICH), Noida.

Access And Availability Remains A Concern

Read More: Type 2 Diabetes Affects Men And Women Differently, New PLOS Study Finds

Vineet Manchanda, Secretary, Hemophilia Society, Lucknow, and Manoj, Hemophilia Federation of India (HFI) North and Agra Chapter, flagged that “Factor VIII, a clotting factor that can prevent bleeding in Hemophilia patients, is very expensive, and the government hospital’s supply is erratic, making availability a major issue".

They also stressed the importance of physiotherapy alongside newer therapies such as prophylaxis.

The experts also highlighted the financial burden of complications, including costly knee or hip replacement surgeries.

Access remains a major concern, with many patients travelling long distances for treatment. “Despite the resources, manpower and factors being invested, we are not achieving the desired results,” Prof Tripathi said.

Experts also called for better use of available budgets to identify and support patients who need treatment the most.

Organized under the aegis of the Uttar Pradesh Hematology Group (UPHG), the UP-Hemophilia Conclave 2026 was held in Lucknow under the theme ‘Uniting Care. Improving Lives.’ It brought together hematologists, physicians, researchers, pathologists, healthcare professionals from hemophilia treatment centers, policymakers and patient groups.

Days after a rare cancer cluster in California's Ladera Ranch made headlines, another revelation has added to the mystery. An unusual number of children and young adults got diagnosed with Ewing sarcoma, a rare type of cancer.

According to Los Angeles Times, between 2013 and 2024, at least six cases of Ewing sarcoma surfaced, leaving the families of patients knee-deep in questions.

According to the American Cancer Society, the cancer is so rare that only 200 children and teenagers are diagnosed in the United States every year.

Mystery Behind Rare Cancer Cluster In Ladera Ranch Deepens

Just when the families of patients were looking for answers, another layer of mystery unraveled after a couple of 20-year-old handwritten notes emerged, signaling towards a probable cause behind the cancer cases.

The notes talk about an oil well at the site. According to The New York Post, the notes appear twice on the Department of Conservation permit, and state, "This well is not to be built over without further considerations."

State oil and gas supervisor William F Guerard Jr, acting state oil and gas supervisor Kenneth Henderson and deputy supervisor RK Baker signed the final report after the well was sealed on February 26, 2002.

The memos warning that no structures must be constructed above the well were reportedly written by engineer Floyd Leeson. They do not reveal why such a warning about the well was issued. Another note had an arrow pointing at the message, with the phrase: "Put on final letter."

According to Los Angeles Times, Henderson could not recall why such a warning was issued, although he believes the way the well was sealed might not be "up to the current standards." Meanwhile, the Department of Conservation said that the notes could have been a "clerical error."

Also read: Cancer Should Be Made Notifiable In India, Say Experts: Here’s Why

A Cancer So Rare That The Cases Caught Attention

Symptoms can initially be easy to dismiss because they may resemble a sports injury or ordinary growing pains. They include persistent bone pain, swelling or a lump, unexplained fever, fatigue or a bone that breaks after relatively minor trauma can sometimes signal the disease.

The cancer can metastasize quickly, which is why persistent or unexplained symptoms need medical evaluation.

Also read: New Clinical Trial Shows Promise In Non-Surgical Treatment Of Early-Stage Rectal Cancer

Can Environmental Factors Contribute To Ewing Sarcoma Risk?

Documents related to the abandonment of an old oil well reportedly contain a handwritten warning from about 20 years ago regarding the development of the site. This prompted fresh questions about what was known about the land before the modern community was built.

There are also concerns about possible pesticide and herbicide exposure, with residents previously urging authorities to investigate environmental factors.

However, none of these potential exposures have been shown to cause the Ewing sarcoma cases in Ladera Ranch. Even though doctors are concerned, they are of the opinion that environmental factors cannot be solely tied to Ewing sarcoma.

The US Food and Drug Administration (FDA) has announced a recall of mangoes sold at Walmart in at least four states because they may be contaminated with Salmonella.

New York-based Panorama Produce "is recalling 302 boxes of size 9 mangoes because they may be contaminated with Salmonella", according to the recall notice.

Recall Issued In Which States?

The mangoes were sold at select Walmart stores in four states:

• Connecticut,
• New Jersey,
• New York
• Pennsylvania.

How To Identify The Recalled Mangoes?

Also read: US FDA Recalls Injectables Over Fiberglass, Steel Particles: See Affected Drugs

The company said that the recalled mangoes are packaged in a Martina-branded case.

Individual mangoes can be identified by a light blue sticker bearing the labels Agrofepac, Produce of Mexico, PLU number 4584 and UPC 07503061948050.

Why Were The Mangoes Recalled?

The recall was initiated after FDA sampling found Salmonella in mangoes grown on the same farm, although those sampled mangoes were not distributed into US commerce.

The recalled mangoes and the sampled mangoes share the same source. Therefore, Panorama Produce initiated the recall. The company, however, stated that no illnesses have been reported to date in connection with the recalled product.

What To Do If You Have The Recalled Mangoes?

Read More: From Dog Food To Fruit Bars: Over 10 Products Recalled In US Over Contamination

The company advised consumers to use the product identifiers above to determine whether their mangoes are included in the recall.

Consumers who have the recalled mangoes should dispose of them or return them to the place of purchase. Anyone who believes they may have become ill should contact a healthcare provider.

Food Recalls In The US

Food safety has become a serious concern in the US in recent months, with a large number of products recalled over contamination, bacterial infections and other health risks.

The recalls involve food products ranging from rice and donuts to eggs and fruit bars, among a host of other products.

Experts blamed federal funding cuts under the Trump administration, which reduced budgets for food inspections by federal agencies and grants to state and local health departments that conduct traceback investigations to determine where outbreaks originate.

What Is Salmonella?

Salmonella is a bacterial infection that commonly causes diarrhea and gastrointestinal illness. Food contaminated with Salmonella bacteria does not usually look, smell or taste spoiled.

Common Symptoms

• Diarrhea
• Stomach cramps
• Vomiting
• Fever.

Anyone can become sick with a Salmonella infection. Most people recover without medical treatment. However, children, older adults and people with weakened immune systems may develop serious illness requiring medical care.

The bacteria can spread by eating contaminated food, through contact with contaminated environments or from person to person.

How To Stay Safe

Health officials have advised consumers to follow recall instructions and avoid eating affected products.

• Refrigerate items promptly
• Cook food products thoroughly
• Wash your hands
• Sanitize surfaces
• Check for recalls
• Wash food before use.